ONC
Beone Medicines·NASDAQ
--
--(--)
--
--(--)
4.86 / 10
Netural
Analyst sentiment is split (Buy 50%, Neutral 50%) with mixed historical performance, while fund‑flow rating is good (7.64/10). Medium and large investors show net inflows, but overall and block trends are negative, yielding a mixed outlook.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-16
InstitutionJefferies
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of ONC?
- ONC holds a Bearish analyst rating, with 50% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.86/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
